A pilot randomized controlled trial of assertive treatment including family involvement and home delivery of medication for young adults with opioid use disorder

Abstract

Background and Aims Although medications for opioid use disorder (OUD), including extended‐release naltrexone (XR‐NTX), have demonstrated effectiveness, adherence is often low. We tested the preliminary efficacy of youth opioid recovery support (YORS), a multi‐component intervention designed to improve engagement and medication adherence for young adults with OUD. Design Single‐site randomized controlled trial with 24‐week follow‐up. Setting Community substance use disorder treatment program in Baltimore, MD, USA. Participants Young adults aged 18–26 years enrolled in inpatient/residential OUD treatment intending to pursue outpatient OUD treatment with XR‐NTX. Twenty‐one participants were randomized to YORS and 20 to treatment as usual (TAU). The analyzed sample was 65.8% male. Intervention and comparator Components of YORS include: (1) home delivery of XR‐NTX; (2) family engagement; (3) assertive outreach; and (4) contingency management for receipt of XR‐NTX doses. The comparator was TAU, which consisted of a standard referral to outpatient care following an inpatient stay. Measurements Primary outcomes were number of XR‐NTX doses received over 24 weeks and relapse to opioid use (defined as ≥ 10 days of use within 28 days) at 24 weeks. Findings Participants in the YORS condition received more XR‐NTX doses [mean = 4.28; standard deviation (SD) = 2.3] compared with those in TAU (mean = 0.70; SD = 1.2), P < 0.01. Participants in the YORS group compared with TAU had lower rates of relapse (61 versus 95%; P < 0.01). Survival analyses revealed group differences on time to relapse with participants in TAU being more likely to relapse sooner compared with participants in the YORS condition [hazard ratio (HR) = 2.72, 95% confidence interval (CI) = 1.26–5.88, P < 0.01]. Conclusions The youth opioid recovery support intervention for extended‐release naltrexone adherence and opioid relapse prevention among young adults with opioid use disorder appeared to improve treatment and relapse outcomes compared with standard treatment.

A comprehensive review of prioritised interventions to improve the health and wellbeing of persons with lived experience of homelessness

“…This systematic review offers a comprehensive evaluation of the ef- Vanderplasschen et al, 2007). Our findings on the benefits of ACT interventions agrees with the conclusions of a reductive effect on rates of relapse amongst youth undergoing opioid rehabilitation (Fishman et al, 2020…”

Youth OUD treatment during and after COVID: Increasing family involvement across the services continuum

“…Assertive outreach to families at the start of MOUD service contact ( Fishman et al, 2020 ), including messaging about the essential value of medication, can greatly facilitate treatment enrollment and preparation. MB was a 23-year-old entered residential treatment for intravenous fentanyl use.…”

Conceptual framework for telehealth strategies to increase family involvement in treatment and recovery for youth opioid use disorder

“…Successful family outreach, especially for traditionally underserved and difficult‐to‐enroll families, requires provider commitment at all levels (e.g., administrative, billing, clinical services) to involving family members and CSOs in services. Assertive family outreach at the start of service contact, including messaging about the essential role of medication, can greatly facilitate OUD treatment preparation (Fishman et al, 2020). Well‐established principles of assertive family outreach include accessibility promotion; planning for and directly addressing common barriers to treatment, both logistical (e.g., insufficient time, lack of resources, agency wait list) and attitudinal (e.g., perceived costs and benefits of treatment, prior unhelpful treatment experiences); and family empowerment (see Becker et al, 2018; Ozechowski & Waldron, 2010).…”